EMA Publishes Revised Guideline on Evaluating Antibacterial Drugs

To help support a global approach to developing new drugs that address antimicrobial resistance (AMR), the European Medicines Agency (EMA) has published a final guideline aimed at aligning data requirements with other countries to meet multiple regulators’ needs.
Source: Drug Industry Daily